Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1016

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection.
Recorded on 03/09/2024. [Show ID: 39768]

Donate to UCTV to support informative \& inspiring programming:
https://www.uctv.tv/donate.

Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.

More videos from: Prostate Cancer Patient Conference.

Continue reading “Systemic Therapy Approaches for Advanced Prostate Cancer” | >

1/ Cloudflare analyzed the most active AI web crawlers on the Internet based on their query volume.

An analysis by Cloudflare shows that Bytespider, Amazonbot, and ClaudeBot are among the most active AI crawlers on the web.

Ad.

Over the past year, Cloudflare has analyzed which AI crawlers with known user agent strings have the highest request volume. Bytedance’s Bytespider crawler tops the list of most active AI web crawlers, followed by Amazonbot, ClaudeBot, and OpenAI’s GPTBot.

Continue reading “OpenAI’s GPTBot gets blocked the most, but it’s not the hungriest AI crawler on the web” | >

So, they get very healthy but only live 24% longer no matter how many more times they use the treatment. I wonder what the telomere effect is. And what they are doing is not the same as what Aubrey’s mouse experiment is doing.

Altos Labs Co-founder and Chief Scientist Rick Klausner participated in a panel discussing efforts to increase human healthspan by combatting age-related diseases at this year’s Aspen Ideas Health conference.

In a panel that included Laura Deming and Kristen Fortney, Klausner discussed an Altos experiment in Spain (likely to be research conducted by Universidad Católica de Murcia and Altos Labs in collaboration with the Hospital Clínic de Barcelona), Klausner reported that if old kidneys are transplanted into young people they do not function nearly as well as transplanting young kidneys – but organ donations donors are getting older and older, and therein lies the rub.

Continue reading “Altos rejuvenation research in mice signposts healthspan extension” | >